Filing Summary
Business Context and Reporting Period
This Form 8-K was filed by DMY Technology Group, Inc. III, a Delaware special purpose acquisition company (SPAC), for events occurring on November 17, 2020. The filing predates the company’s subsequent association with IonQ and does not report IonQ operating results.
Key Financial and Transaction Metrics
- The company completed its initial public offering of 30,000,000 units at $10.00 per unit, generating $300.0 million of gross IPO proceeds. The total includes 2,500,000 units issued upon the underwriters’ full exercise of their over-allotment option.
- Each unit consisted of one Class A common share and one-fourth of a redeemable warrant. Each whole warrant is exercisable for one Class A share at $11.50 per share, subject to adjustment.
- The company separately issued 4,000,000 private placement warrants to its sponsor at $2.00 per warrant, generating $8.0 million of gross proceeds.
- $300.0 million was deposited into a U.S.-based trust account at JPMorgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee. The deposit comprised $294.0 million of IPO proceeds, including a $10.5 million deferred underwriting discount, and $6.0 million from the private placement warrants.
- The filing does not provide revenue, profit, operating cash flow, margins, debt, or broader liquidity metrics beyond the IPO and trust-account funding.
Material Changes Versus Prior Comparable Period
The filing reports the company’s IPO and concurrent private placement but does not provide a prior-period income statement or comparable operating results. Accordingly, changes in revenue, earnings, cash flow, margins, or debt cannot be assessed from this filing.
Outlook, Risks, Contingencies, and Unusual Items
- The filing is focused on capitalization and the establishment of the trust account; it does not provide management guidance, an operating outlook, or detailed risk-factor disclosures.
- The $10.5 million deferred underwriting discount is an unusual transaction-related item included in the stated IPO proceeds deposited into the trust account.
- The filing does not describe a completed business combination, target company, or related transaction terms.
- The trust-account balance and warrant terms are important contingencies for evaluating the company’s future transaction financing and potential shareholder dilution.
Facts Investors Should Verify
- Confirm that the filing registrant is DMY Technology Group, Inc. III, rather than IonQ, Inc., and establish the subsequent corporate transaction history.
- Verify the $300.0 million trust-account deposit and its composition of $294.0 million from the IPO and $6.0 million from private placement warrant proceeds.
- Review the audited November 17, 2020 balance sheet included as Exhibit 99.1 for transaction expenses, liabilities, and the reported trust-account balance.
- Confirm the number, exercise price, adjustment provisions, and potential dilution associated with public and private placement warrants.